Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease - Test2 - elhamkhani - TriplyDB

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

http://www.wikidata.org/entity/Q24312938

about

Association claims in the sequencing era Modeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns Genes associated with Alzheimer's disease: an overview and current status Toward precision medicine in Alzheimer's disease The Increasing Importance of Gene-Based Analyses Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease The genetic landscape of Alzheimer disease: clinical implications and perspectives Rare-variant association analysis: study designs and statistical tests Genetic heterogeneity in Alzheimer disease and implications for treatment strategies Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways Bridging the gap between statistical and biological epistasis in Alzheimer's disease Mechanism of enzymatic reaction and protein-protein interactions of PLD from a 3D structural model.Towards Personalized Intervention for Alzheimer's Disease Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways The phospholipase D superfamily as therapeutic targets Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities Additional mechanisms conferring genetic susceptibility to Alzheimer's disease TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits Genetic variants in Alzheimer disease - molecular and brain network approaches Progress in methods for rare variant association Gene-based rare allele analysis identified a risk gene of Alzheimer's disease Genomic variants, genes, and pathways of Alzheimer's disease: An overview.Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease.A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death.Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.RNA-Seq data mining: downregulation of NeuroD6 serves as a possible biomarker for alzheimer's disease brains.iGWAS: Integrative Genome-Wide Association Studies of Genetic and Genomic Data for Disease Susceptibility Using Mediation Analysis.Leveraging Identity-by-Descent for Accurate Genotype Inference in Family Sequencing Data.Review: High-performance computing to detect epistasis in genome scale data sets.Family-based genome scan for age at onset of late-onset Alzheimer's disease in whole exome sequencing data Efficient Software for Multi-marker, Region-Based Analysis of GWAS Data.Association and interaction effects of Alzheimer's disease-associated genes and lifestyle on cognitive aging in older adults in a Taiwanese population.Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer's disease Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.Targeted resequencing and systematic in vivo functional testing identifies rare variants in MEIS1 as significant contributors to restless legs syndrome.Epidemiology of dementia in Central Africa (EPIDEMCA): protocol for a multicentre population-based study in rural and urban areas of the Central African Republic and the Republic of Congo.Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibition

P2860

50eaa142bf1a35458a386603e82b780df0c9ebd0 957e5dc0db8410545c83b233f1e7df44e2e78b72

P248

Q24273315-F7772F86-DB58-4866-93BD-2C26667316F7 Q26745513-6B5BD98E-4A74-4558-B646-5CB4FAADB44F Q26747803-124BEE9F-9EC9-4614-AB72-14E58AE7CF6C Q26748939-64CD80FD-8CA1-49F1-A5D6-D81F78E24CF3 Q26750946-3B3C3854-AB7E-425F-B73D-60DF6E51D1D4 Q26767289-7684B8D4-1423-4DD6-B8D0-8BFD9D660993 Q26769957-C88BBB90-FEF8-4B2D-A0C8-04A814B98EA2 Q26777969-4CCAE993-BCEC-470D-B216-8585786AFCB9 Q26796582-B94B96C0-9EAF-408A-8B48-7F69481A62F9 Q26852733-9BBEDE40-16A6-4EBC-A8CE-9203508848B3 Q26995802-86C89243-2D7F-4A32-B33E-4AA5C1DF7907 Q27014964-BC41F1AF-7C3D-4D9B-8D5B-A2CBC99D7100 Q27022673-4A95783E-E0AE-4761-8988-5D6FD2D612E8 Q27321589-753C357E-4A04-4B2B-A333-B49B0E2B5691 Q28080098-0B0FED88-2347-4E24-B3A3-E2618A9CAD6C Q28081678-D98A2FAE-0D6D-441D-83FA-427B1C253752 Q28082479-92498A24-7925-46AE-AF2E-AD71D3BCE6A4 Q28086879-00B56D6F-6376-41F6-B25A-BF753A45A021 Q28391511-C88C2C54-6DEC-4D49-943D-5CCE13E9DFC1 Q28545832-B4B268FB-E77E-4793-B349-D2D05C8495BE Q28596011-3F6A60C9-CCB9-4767-9C26-32D4924F813B Q28601645-03851D25-B565-4A93-89A7-6C83A12DAF03 Q28654541-019A02F2-BA6B-4F5A-8BBA-B88B4AB7CC6B Q30240093-CB631EE9-DAEA-457C-BC93-759731077668 Q30490228-50931243-84FD-4531-BEA8-A40540EE3F78 Q30616995-72D54905-2F82-44EA-8CCC-4CE20701AFCC Q30845482-36F85C10-42F1-45B4-AC8A-775B982DA5CC Q30882224-F4527939-E3A4-4821-81A3-AF31EE37BD26 Q30956245-1CECABC5-C208-4B67-8DD8-1C31D7120988 Q30965486-0EF13287-AFBC-42F4-BD90-C3470AEAE9D3 Q30987292-F1D46FDF-C738-4288-BB49-C6E880B4C2E5 Q30995743-FD187BD8-0398-411F-BC1E-8755431C7D7D Q31044244-5C6957E2-4B5E-44DD-83CF-0CF997B178C6 Q33648361-5D9455E1-1E3B-4901-B1D6-A51A796EC0E8 Q33726449-8EDA0124-ECA4-40C4-90C7-AB53E20D2951 Q33770976-6A686329-AA30-47FC-8611-665D6E80B4AC Q33858791-9DCA60B8-EB9E-4F23-9611-ADB17BE1DA79 Q33897058-30F2F9F2-B5F8-43FD-AA80-0222EB407269 Q34133701-A85AD06D-3321-4F4B-B277-BAC9ABBBDDB1 Q34170578-19879D0B-88CC-40B7-AD70-E04B3D4A2E90

P2860

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

http://www.wikidata.org/entity/Q24312938

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@ast

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@bar

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@de

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@en

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@en-gb

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@fr

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@nl

type

label

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@ast

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@bar

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@de

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@en

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@en-gb

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@fr

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@nl

prefLabel

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@ast

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@bar

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@de

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@en

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@en-gb

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@fr

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@nl

P1433

Q24312938-146F8F2B-956D-47C9-8F42-46431EB828E6

P1476

Q24312938-C8E9AB81-2C8B-45FB-8F24-44B24E7D1FAC

P2093

Q24312938-076677C0-937D-4D67-98A1-705F5EEF9D06

Q24312938-09E28ACB-80BB-451F-A927-BD0D77896DC5

Q24312938-0A228314-2558-4316-862A-80779BAC1ACE

Q24312938-0DBCC819-C108-4BC0-B8EB-3920A5709D85

Q24312938-14DC0E27-D904-4A8B-9AF9-7D9CE48A1429

Q24312938-16869B99-0DC5-404F-9E57-7B9E36EE5D7D

Q24312938-1BA102A8-4356-48AD-89C4-2B6E6889B16C

Q24312938-1CB03319-8790-4006-8856-3115C9ADB79A

Q24312938-1CC30051-A51B-40C0-9E12-3C38848C6E6D

Q24312938-1D0C4A08-EC39-4DB0-BA9E-1FEDA7EDC8F8

P2860

Q24312938-0678AAFB-8E8D-4F1A-9BF5-BCE8F8605905

Q24312938-1611F8AC-CC80-4564-BF9A-A39847EDAC3D

Q24312938-168D41A6-E840-4B48-A686-A4830E0A0D0B

Q24312938-17FAD87A-DFBE-4623-9851-BF8CD1C7B063

Q24312938-1D3D2CD7-5802-44E4-A9D8-31FB1769304B

Q24312938-1D511979-3FF4-4383-AE3C-FCCA04C3F6B4

Q24312938-20D62766-2EA6-40C7-9411-76A279E429DF

Q24312938-30AAABC1-7090-436F-86E8-7010D9ACAEAF

Q24312938-31B4610A-79D8-4E44-B757-8C86CE09C9CA

Q24312938-33FEA0C2-BD98-47E7-99ED-E2D1F7D0705C

P2888

Q24312938-E81DED28-9EAC-4768-9B48-893309A4C671

P304

Q24312938-18DDE57D-CB10-4648-A311-9EDE42B68703

P31

Q24312938-0CFA1C18-CFF6-456D-9449-A8DBABC7B644

P3181

Q24312938-4B5CA5CC-1BDB-4879-B7D5-0D31277748E5

P356

Q24312938-7F1755E6-D862-4D1B-B1AB-AB979FA1609B

P407

Q24312938-E4E09CF2-9C51-4DE9-BA3C-E55C8D0DCB27

P433

Q24312938-D6333DD3-AB1E-4483-B850-82C3F2B35F65

P478

Q24312938-BF587926-66E8-4F21-AAA8-4C3F24CD848C

P50

Q24312938-012E01BB-2EB9-473B-9AD8-026545633827

Q24312938-0C2FE8AB-9267-42FB-9C29-DAEC4208D2C0

Q24312938-0C5878AD-7FE9-48D7-8F69-720A578CE641

Q24312938-0CD38227-048B-4E3F-A4CA-EEA763FDDC4C

Q24312938-117AA090-7BB4-4F4F-B293-F7A5605626BA

Q24312938-1AE32B13-B362-4063-B0B9-08A304625E2D

Q24312938-21BA7674-6E29-4BAA-8B7D-45198ADB10FE

Q24312938-28198D2D-DE47-41D6-9DD2-4C651AFDB33F

Q24312938-2BAC1F7D-AF36-4C19-AC04-B729817A3743

Q24312938-3490FF2D-4986-4619-90F9-41FC4980A032

P577

Q24312938-39900A1D-D05A-4C12-99C7-409FCA27EAC3

P5875

Q24312938-C6EFB04C-6250-4670-AA48-D380CB4E0D71

P6179

Q24312938-4C3C1CED-1FA6-4D5A-A845-AB716C811885

P698

Q24312938-340983DC-1695-43EF-9499-C7A95BF90876

P921

Q24312938-C47047A3-3D99-46A8-A86F-72F3CE5735B6

P932

Q24312938-2FC670B2-19E6-437A-80A5-27C2291A15A2

P3181

P356

P1433

P1476

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

@en

P2093

A David Smith

http://www.w3.org/2001/XMLSchema#string

Amanda T Jeng

http://www.w3.org/2001/XMLSchema#string

Anne Braae

http://www.w3.org/2001/XMLSchema#string

Breanna Cooper

http://www.w3.org/2001/XMLSchema#string

Cameron Schmutz

http://www.w3.org/2001/XMLSchema#string

Celeste Sassi

http://www.w3.org/2001/XMLSchema#string

Christopher D Corcoran

http://www.w3.org/2001/XMLSchema#string

Christopher Medway

http://www.w3.org/2001/XMLSchema#string

Clive Holmes

http://www.w3.org/2001/XMLSchema#string

Colin Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Exome-sequencing confirms DNAJC5 mutations as cause of adult neuronal ceroid-lipofuscinosis

SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease

WGCNA: an R package for weighted correlation network analysis

TREM2 Variants in Alzheimer's Disease

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization

Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation.

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

P2888

P304

550-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1384574

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE12825

http://www.w3.org/2001/XMLSchema#string

P407

P433

7484

http://www.w3.org/2001/XMLSchema#string

P478

505

http://www.w3.org/2001/XMLSchema#string

P50

Stuart Pickering-Brown

Ekaterina Rogaeva

Nigel M. Hooper

Bruno A Benitez

Carlos Cruchaga

Patrick G. Kehoe

Michael E. Weale

P577

2014-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260713296

http://www.w3.org/2001/XMLSchema#string

P6179

1033727401

http://www.w3.org/2001/XMLSchema#string

P698

24336208

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4050701

http://www.w3.org/2001/XMLSchema#string